Lior Soday

Lior Soday is a Senior Scientist at Kesmalea Therapeutics with extensive experience in research, particularly focusing on the role of prenylation and farnesyl transferase inhibitors in cancer, as well as target identification studies. Lior's background includes a PhD in Natural Sciences from the University of Cambridge, where they also worked as a Researcher and Undergraduate Supervisor. Additionally, Lior has been involved in various research placements and projects in different institutions, showcasing a strong dedication to the field of medical science.